Section Arrow
HRTX.NASDAQ
- Heron Therapeutics
Quotes are at least 15-min delayed:2026/06/02 11:32 EDT
Regular Hours
Last
 0.54165
-0.28555 (-34.52%)
Day High 
0.69 
Prev. Close
0.8272 
1-M High
1.34 
Volume 
8.07M 
Bid
0.5416
Ask
0.5417
Day Low
0.5002 
Open
0.675 
1-M Low
0.82 
Market Cap 
156.57M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.87 
20-SMA 0.97 
50-SMA 0.95 
52-W High 2.3 
52-W Low 0.7362 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.18/--
Enterprise Value
297.21M
Balance Sheet
Book Value Per Share
0.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
154.90M
Operating Revenue Per Share
0.62
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
EVGNEvogene Ltd.0.6087-0.0743-10.88%-- 
FULCFulcrum Therapeutics2.935-3.485-54.28%-- 
AIMAIM ImmunoTech Inc.0.8169-0.0817-9.09%-- 
ADTXAditxt Inc.0.1149+0.0019+1.68%-- 
ABVXAbivax SA73.36-56.33-43.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.